Overview

Clinical Efficacy and Safety Evaluation of HCP1202 in COPD Patients

Status:
Unknown status
Trial end date:
2018-04-01
Target enrollment:
Participant gender:
Summary
A phase 3 study to evaluate efficacy and safety of HCP1202
Phase:
Phase 3
Details
Lead Sponsor:
Hanmi Pharmaceutical Company Limited